# Anti-platelet Precision Medicine to Prevent Stroke Early Progression and Recurrence (PRECISE)

> **NCT03701360** · — · COMPLETED · sponsor: **Asan Medical Center** · enrollment: 1199 (actual)

## Conditions studied

- Stroke

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT03701360
- **Lead sponsor:** Asan Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-30
- **Primary completion:** 2021-07-14
- **Final completion:** 2021-07-14
- **Target enrollment:** 1199 (ACTUAL)
- **Last updated:** 2022-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03701360

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03701360, "Anti-platelet Precision Medicine to Prevent Stroke Early Progression and Recurrence (PRECISE)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03701360. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*